Form 4: Elanco Animal Health CEO Acquires Deferred Stock Units

Elanco Animal Health's CEO, Jeffrey N. Simmons, acquired 198.0858 deferred stock units, convertible to common stock, on November 15, 2024.

Summary

• Jeffrey N. Simmons, the CEO and a director of Elanco Animal Health Inc., acquired 198.0858 deferred stock units on November 15, 2024.
• These deferred stock units represent the right to receive one share of Elanco common stock or the cash equivalent.
• The units will settle in cash or shares following termination of employment or during a specified future year, as per the Executive Deferral and Stock Match Plan.
• The price of the underlying common stock at the time of the transaction was $13.98.
• Following the transaction, Mr. Simmons directly owns 4,324.417 shares of common stock.

Sentiment

Score: 6

Explanation: The document reflects a routine transaction related to executive compensation. It is neither particularly positive nor negative, but indicates continued alignment of management with the company's performance.

Positives

• The acquisition of deferred stock units by the CEO could be seen as a positive sign of confidence in the company's future performance.

Future Outlook

The deferred stock units will settle in cash or shares following termination of employment or during a specified future year, according to the Executive Deferral and Stock Match Plan.

Industry Context

This transaction is a routine filing related to executive compensation and stock ownership, which is common in publicly traded companies within the animal health industry.

Comparison to Industry Standards

• Executive compensation packages often include deferred stock units as a way to align management's interests with those of shareholders.
• Similar transactions are regularly reported by executives in comparable companies such as Zoetis and IDEXX Laboratories.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it indicates the CEO's continued investment in the company.

Key Dates

Keywords

Elanco Animal Health, Jeffrey N. Simmons, Deferred Stock Units, Executive Compensation, Stock Ownership, SEC Form 4